Sen-Jam Pharmaceutical
Huntington
About Sen-Jam Pharmaceutical
Sen-Jam Pharmaceutical is a medical company developing novel pharmaceutical solutions for large unmet needs using the development pathway. The company focused on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVID-19, and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, and even the infamous hangover. Sen-Jam Pharmaceutical develops consumer healthcare products that help people stay strong by mitigating common side effects from medicines and everyday living. The company's global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.3M
- Last round: Series Unknown (Jan 2025)
- Website: sen-jam.com
- Phone: 201.400.8083
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sen-jam-pharmaceutical-105026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.